Alberto Tommasini Selected Research

Alberto Tommasini Research Topics

Disease

17	Inflammation (Inflammations) 01/2024 - 08/2008
14	Mevalonate Kinase Deficiency 05/2024 - 02/2007
8	Infections 01/2023 - 03/2005
7	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2018 - 03/2014
7	Crohn Disease (Crohn's Disease) 11/2016 - 12/2007
6	Celiac Disease (Celiac Sprue) 07/2009 - 11/2002
4	Chronic Granulomatous Disease 10/2022 - 03/2005
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 04/2014
4	Rare Diseases (Rare Disease) 05/2018 - 06/2010
4	Cryopyrin-Associated Periodic Syndromes 09/2015 - 10/2003
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2023 - 01/2018
3	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 09/2023 - 10/2018
3	COVID-19 09/2023 - 01/2020
3	Rheumatoid Arthritis 09/2023 - 10/2020
3	Immune System Diseases (Immune Disorders) 01/2023 - 08/2011
3	Bites and Stings (Sting) 06/2021 - 01/2018
3	Colitis 01/2021 - 02/2012
3	Ulcerative Colitis 10/2020 - 11/2016
3	Autoimmune Lymphoproliferative Syndrome 06/2019 - 02/2012
3	Fever (Fevers) 02/2018 - 03/2005
2	Uveitis 09/2023 - 01/2020
2	Familial Mediterranean Fever (Periodic Disease) 11/2022 - 06/2008
2	Neoplasms (Cancer) 07/2021 - 04/2012
2	Aphthous Stomatitis (Aphthous Ulcer) 05/2021 - 02/2018
2	Agammaglobulinemia (Hypogammaglobulinemia) 01/2021 - 01/2020
2	Aneurysm (Aneurysms) 01/2019 - 08/2014
2	Inborn Genetic Diseases (Disease, Hereditary) 08/2018 - 12/2008
2	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 01/2014
2	IgA Deficiency 10/2013 - 07/2006
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 02/2024
1	Severe combined immunodeficiency due to adenosine deaminase deficiency 02/2024
1	Sensorineural Hearing Loss 01/2024
1	Diabetes Mellitus 01/2024
1	Erythropoietic Protoporphyria 11/2023
1	Pulmonary Hypertension 10/2023
1	hyperzincemia and hypercalprotectinemia 10/2023
1	Dyspnea (Shortness of Breath) 10/2023
1	Pulmonary Arterial Hypertension 10/2023
1	Arthralgia (Joint Pain) 11/2022
1	Hereditary Autoinflammatory Diseases 11/2022
1	autosomal dominant familial Periodic fever 11/2022
1	Tenosynovitis 04/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Malnutrition (Nutritional Deficiencies) 07/2021

Drug/Important Bio-Agent (IBA)

8	InterferonsIBA 07/2023 - 04/2015
7	AntibodiesIBA 08/2018 - 11/2002
5	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022 - 02/2007
5	CytokinesIBA 01/2021 - 07/2011
5	SteroidsIBA 01/2021 - 04/2015
5	CholesterolIBA 04/2019 - 05/2010
4	EnzymesIBA 01/2022 - 03/2005
4	Glutens (Glutelin)IBA 08/2011 - 02/2004
4	Terpenes (Terpenoids)IBA 06/2010 - 02/2007
3	canakinumab FDA Link 05/2024 - 07/2020
3	AutoantibodiesIBA 01/2024 - 01/2021
3	Sirolimus (Rapamycin)FDA Link 01/2020 - 01/2016
3	Mevalonic Acid (Mevalonate)IBA 04/2016 - 06/2010
3	Immunoglobulin A (IgA)IBA 12/2014 - 08/2003
3	Protein Glutamine gamma Glutamyltransferase 2IBA 05/2005 - 08/2003
2	Adenosine DeaminaseIBA 02/2024 - 10/2017
2	Antimalarials (Antimalarial Agents)IBA 01/2024 - 01/2018
2	Janus Kinase InhibitorsIBA 01/2024 - 10/2020
2	Immunosuppressive Agents (Immunosuppressants)IBA 10/2023 - 01/2020
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2023 - 01/2019
2	Interferon Type IIBA 07/2023 - 01/2021
2	Complement System Proteins (Complement)IBA 01/2023 - 01/2020
2	Colchicine FDA LinkGeneric 11/2022 - 06/2008
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 06/2021 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 11/2016
2	Immunoglobulin M (IgM)IBA 01/2021 - 01/2019
2	C-Reactive ProteinIBA 01/2021 - 01/2017
2	Immunoglobulin G (IgG)IBA 01/2020 - 08/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 11/2016
2	5-(tetradecyloxy)-2-furancarboxylic acid (TOFA)IBA 07/2016 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 09/2015 - 12/2008
2	NucleotidesIBA 03/2014 - 12/2007
2	Interleukin-10 ReceptorsIBA 03/2014 - 02/2012
2	GliadinIBA 08/2011 - 02/2004
2	geranylgeranyl pyrophosphate (geranylgeranyl diphosphate)IBA 07/2011 - 06/2010
2	SterolsIBA 06/2010 - 02/2007
2	AutoantigensIBA 05/2005 - 02/2004
2	TransglutaminasesIBA 01/2004 - 11/2002
1	Busulfan (Busulfex)FDA Link 02/2024
1	Cimetidine (Biomet)FDA LinkGeneric 11/2023
1	Vasodilator Agents (Vasodilators)IBA 10/2023
1	tocilizumab (atlizumab)FDA Link 09/2023
1	baricitinibIBA 11/2022
1	Janus KinasesIBA 11/2022
1	Methotrexate (Mexate)FDA LinkGeneric 04/2022
1	Interleukin-1 (Interleukin 1)IBA 01/2022
1	Adenosine Diphosphate (ADP)IBA 01/2022
1	blinatumomabIBA 01/2022
1	Rituximab (Mabthera)FDA Link 07/2021

Therapy/Procedure

16	Therapeutics 11/2023 - 02/2007
3	Hematopoietic Stem Cell Transplantation 10/2022 - 12/2015
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2015
2	Precision Medicine 01/2021 - 01/2018
1	Slit Lamp 09/2023
1	Biological Therapy 04/2022
1	Parenteral Nutrition 07/2021